Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study
Connie Celum(University of Washington), Jorge Sánchez(Universitat Politècnica de València), Mina C. Hosseinipour, Breno Santos(Hospital Nossa Senhora da Conceição), Thomas Campbell(University of Colorado Anschutz Medical Campus), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Khuanchai Supparatpinyo(Chiang Mai University), James Hakim(University of Zimbabwe), N. Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Umesh Lalloo(Wentworth Hospital), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Mulinda Nyirenda(University of Malawi), Anne Cent(University of Washington), Ting Hong(Sun Yat-sen University), Rhoda Ashley Morrow(University of Namur), Cynthia Firnhaber, Cynthia Riviere(Hôpital Necker-Enfants Malades)
Cited by 10
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k